-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Celestica, Lowers Price Target to $406

Benzinga·08/07/2026 10:46:28
Listen to the news
Barclays analyst Tim Long maintains Celestica (NYSE:CLS) with a Overweight and lowers the price target from $430 to $406.